Skip to main content
Premium Trial:

Request an Annual Quote

NIH Extends CAP Deadline; Initiative Links SBIR Awardees With Investors to Help Commercialize Technology

NEW YORK (GenomeWeb News) - The National Institutes of Health extended the submission date for its Commercialization Assistance Program to Aug. 7.
 
The NIH SBIR CAP connects SBIR Phase II awardees with partners and investors to help move the products into the marketplace. The program is appropriate for researchers with clinical products looking for investments or alliances.
 
STTR awardees are not eligible to participate at this time.
 
The program is limited to approximately 125 awardees.
 
A description of the program can be found here.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.